Introduction: TB is one of the major public health problems in India, with the largest reported epidemics according to WHO. India is ranked at number 38 at a global level in terms of the TB incidence rate. However, being the second most populous country in the world, it has 26% of global burden of TB and has the highest number of TB cases occurring annually.

Objectives: The aim of this study was to assess the profile of the different categories of TB patients in Jharkhand for the year 2019 who are registered in the NIKSHAY web‑based online portal.

Methodology: Data was obtained from the NIKSHAY portal of State TB Cell, Jharkhand. The secondary data of the Nikshay portal under NTEP was analysed to enumerate all the variables in the web‑based portal. Data from the state of Jharkhand from January 1to December 31, 2019 was obtained.

Results: A total of 57,504 TB patients were notified. Most of patients were in the 15-44 years age group with males being 69%, most belonged to Drug sensitive category(98%) and Pulmonary TB(86%) being most common. Among extra pulmonary the most common site was Abdominal TB(34%). Treatment success rate was 83%.

Discussion: The working age group is mostly affected as shown by Ali SIFI et al. 2.23 M:F ratio was comparable to a study by Horton et al.

Conclusion: We need to train our data entry officials and monitor their work at state and district level. Low UDST may result in missing drug resistant cases.

Keywords: TB profile, outcome, UDST, NIKSHAY.

1. Global tuberculosis control. WHO report. WHO/HTM/TB/2006.362. Geneva: World Health Organization, 2006.
2. WHO Global TB Report 2021, India. Last accessed on 08/02/2022 (https://www.who.int/teams/global-tuberculosis-programme/tb-reports)
3. Sulis, G., Roggi, A., Matteelli, A. and Raviglione, M. Tuberculosis: Epidemiology and Control. Mediterr J Hematol Infect Dis 2014, 6(1):e2014070.
4. Garg T, Gupta V, Sen D, et al. Prediagnostic loss to follow-up in an active case finding tuberculosis programme: a mixedmethods study from rural Bihar, India. BMJ Open. 2020;10, e033706.
5. Factsheet: End TB Strategy and targets. Available from: https://www.who.int/tb/post2015_TBstrategy.pdf?ua¼1 Last accessed on 21 July 2020.
6. National Strategic Plan for Tuberculosis Elimination 2017- 2025. Available from: https://tbcindia.gov.in/WriteReadData/ NSP%20Draft%2020.02.2017%201.pdf Last accessed on 21 July 2020..
7. National Strategic Plan To End Tuberculosis In India2020–25. Accelerating The National Response For Expanded Coverage And Sustained Impact At Scale To End Tb In India.Available from: https://tbcindia.gov.in/showfile.php?lid=3577, Last accessed on 7 Feb 2022
8. Ali, S. I. F. I., Shinde, J., Khetarpal, M., & Pawar, M. H. A descriptive analysis of TB patients registered for treatment using the Web based Case based Portal (NIKSHAY), in the district Byculla of Mumbai, India. South American Journal of Public Health.Special Edition May 2016. Available at https://www.texilajournal.com/thumbs/article/Public%20Health_SE_May2016_Article_8.pdf. Accessed on 4/2/2022.
9. Uplekar M, Pathania V, Raviglione M. Private practitioners and public health: Weak links in tuberculosis control. Lancet 2001;358:912-6.
10. Toolkit for analysis and use of routine health facility data, Guidance for tuberculosis programme managers, Working document, December,2019. Page 14. Available from , accessed on 9^th Feb 2022
11. Babu DS, John KR, Babu R. Profile of the tuberculosis patients enrolled in nikshay portal (a web-based online portal) from Chittoor district: A monitoring tool for tuberculosis in India. Med J DY Patil Vidyapeeth 2020;13:460-4
12. Horton KC, MacPherson P, Houben RM, White RG, Corbett EL. Sex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. PLoS Med. 2016;13(9): e1002119. Published 2016 Sep 6. doi:10.1371/journal.pmed.1002119
13. Institute of Medicine (US). Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy, and the Indian Council of Medical Research. Washington (DC): National Academies Press (US); 2012. 2, Drug-Resistant TB in India.Available from: https://www.ncbi.nlm.nih.gov/books/NBK100386/. Accessed ON 9^TH Feb 2022.
14. Shivekar, S.S., Kaliaperumal, V., Brammacharry, U. et al.Prevalence and factors associated with multidrug-resistant tuberculosis in South India. Sci Rep 10, 17552 (2020). https://doi.org/10.1038/s41598-020-74432-y. Accessed on 10^th Feb, 2022.
15. Izudi, J., Tamwesigire, I.K. & Bajunirwe, F. Treatment success and mortality among adults with tuberculosis in rural eastern Uganda: a retrospective cohort study. BMC Public Health20, 501 (2020). https://doi.org/10.1186/s12889-020-08646-0, Accessed on 10^th Feb 2022.

Dr Smiti Narain

Medical Officer State TB Cell